Literature DB >> 17028882

Strategies to screen for adrenal suppression in children with asthma should take account of compliance with inhaled corticosteroids.

Malcolm Brodlie1, Ann McMurray, Patricia M Crofton, Louise Bath, Steve Cunningham.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17028882     DOI: 10.1007/s00431-006-0260-7

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


× No keyword cloud information.
  5 in total

1.  The use of inhaled corticosteroids during childhood: plus ça change...

Authors:  G Russell
Journal:  Arch Dis Child       Date:  2004-10       Impact factor: 3.791

2.  Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom.

Authors:  G R G Todd; C L Acerini; R Ross-Russell; S Zahra; J T Warner; D McCance
Journal:  Arch Dis Child       Date:  2002-12       Impact factor: 3.791

3.  Standard and low-dose short adrenocorticotropin test compared with insulin-induced hypoglycemia for assessment of the hypothalamic-pituitary-adrenal axis in children with idiopathic multiple pituitary hormone deficiencies.

Authors:  N Weintrob; E Sprecher; Z Josefsberg; C Weininger; Y Aurbach-Klipper; D Lazard; M Karp; A Pertzelan
Journal:  J Clin Endocrinol Metab       Date:  1998-01       Impact factor: 5.958

4.  Adrenal suppression from high-dose inhaled fluticasone propionate in children with asthma.

Authors:  D Sim; A Griffiths; D Armstrong; C Clarke; C Rodda; N Freezer
Journal:  Eur Respir J       Date:  2003-04       Impact factor: 16.671

Review 5.  Science review: mechanisms of impaired adrenal function in sepsis and molecular actions of glucocorticoids.

Authors:  Hélène Prigent; Virginie Maxime; Djillali Annane
Journal:  Crit Care       Date:  2004-05-25       Impact factor: 9.097

  5 in total
  1 in total

1.  Compliance with inhaled corticosteroids is important when considering adrenal suppression.

Authors:  Malcolm Brodlie; Steven Cunningham
Journal:  Arch Dis Child       Date:  2007-04       Impact factor: 3.791

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.